Skip to content
November 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • Headline: METAvivor Announces Strategic Migration to Bloomerang Fundraising Platform to Bolster Peer-to-Peer Research Funding Initiatives
  • Patient Advocacy and Support

Headline: METAvivor Announces Strategic Migration to Bloomerang Fundraising Platform to Bolster Peer-to-Peer Research Funding Initiatives

Layla Zulfa November 2, 2026 8 minutes read
headline-metavivor-announces-strategic-migration-to-bloomerang-fundraising-platform-to-bolster-peer-to-peer-research-funding-initiatives

ANNAPOLIS, MD — METAvivor Research and Support, a leading non-profit organization dedicated to funding critical research for stage IV metastatic breast cancer (MBC), has officially announced a significant transition in its digital infrastructure. The organization is migrating its primary peer-to-peer (P2P) fundraising operations from GoFundMe Pro (formerly known as Classy) to Bloomerang Fundraising. This move, which became effective this fall, represents a strategic effort to streamline donor engagement and maximize the efficiency of its fundraising ecosystem.

As the organization sunsets its previous platform, METAvivor leadership has emphasized that this transition is designed to provide a more robust, integrated experience for the thousands of volunteers and donors who sustain its mission. This report examines the technical details of the migration, the timeline for implementation, the broader context of metastatic breast cancer funding, and the implications for the future of philanthropic technology.


I. Main Facts: The Transition to Bloomerang Fundraising

The transition marks the end of METAvivor’s long-standing reliance on GoFundMe Pro, a platform that has undergone several corporate rebrandings and structural changes in recent years. By moving to Bloomerang, METAvivor aims to leverage a platform specifically engineered for donor retention and comprehensive relationship management.

Key Technical Details:

  • Platform Decommissioning: As of the current fall season, all fundraising pages hosted on the GoFundMe Pro/Classy platform will no longer be active. Donors attempting to access legacy pages will be redirected or informed of the platform’s expiration.
  • Data Migration: METAvivor has confirmed that existing fundraising pages, donor histories, and campaign data have been successfully migrated to the Bloomerang environment. This ensures that long-term supporters do not lose the historical context of their advocacy.
  • The Bloomerang Advantage: Unlike general crowdfunding tools, Bloomerang is a constituent relationship management (CRM) system that integrates fundraising tools directly with donor data. For METAvivor, this means better tracking of how peer-to-peer campaigns contribute to the organization’s overarching goal of funding 100% of research grants through public donations.

The organization has urged all active fundraisers to verify their new accounts. Information regarding the migration was disseminated via electronic correspondence in late July, providing users with the necessary credentials to access their updated dashboards.


II. Chronology of the Platform Migration

The shift from GoFundMe Pro to Bloomerang was not an overnight decision but a planned logistical rollout aimed at minimizing disruption during the high-activity autumn fundraising season.

  • Initial Evaluation (Early 2024): METAvivor’s internal digital strategy team identified the need for a more unified system that could bridge the gap between social fundraising and donor stewardship.
  • The July 27 Milestone: On July 27, METAvivor initiated the first major phase of the transition by sending out comprehensive "access emails" to all existing fundraisers. These emails contained unique links to the new Bloomerang-hosted dashboards, allowing users to customize their pages ahead of the fall campaign cycle.
  • Integration Phase (August – September): During this period, the organization operated in a hybrid state, ensuring that ongoing campaigns were not abruptly cut off while the Bloomerang backend was stress-tested.
  • Final Transition (Fall 2024): The official "sunset" of GoFundMe Pro pages began this fall. METAvivor confirmed that the legacy pages would be deactivated to ensure that all financial contributions are processed through the new, more secure system.
  • Ongoing Support Phase: Following the deactivation, the organization has entered a permanent support phase, where the administrative team (reachable at [email protected]) is manually assisting legacy donors and fundraisers who may have missed the initial migration window.

III. Supporting Data: The Critical Role of P2P Fundraising in MBC Research

To understand why a platform shift is significant, one must look at the data surrounding metastatic breast cancer (MBC) and the unique funding model METAvivor employs.

The Funding Gap
Metastatic breast cancer—the stage where cancer has spread beyond the breast to vital organs—is the only breast cancer that kills. Despite this, historical data suggests that only 2% to 5% of all breast cancer research funding is dedicated to stage IV research. The vast majority of funding is directed toward prevention, early detection, and awareness of early-stage disease.

METAvivor’s Impact Metrics:

  • 100% Commitment: METAvivor remains one of the few organizations globally where 100% of every donation (unless otherwise specified) goes directly to MBC research grants.
  • Peer-to-Peer Power: P2P fundraising accounts for a substantial portion of METAvivor’s annual revenue. These are grassroots campaigns—memorial walks, birthday fundraisers, and community events—driven by patients and their families.
  • The "Pink" Disparity: While "Pink Ribbon" campaigns raise billions, MBC advocates point to a disparity in "lives saved vs. dollars spent." By moving to Bloomerang, METAvivor intends to use data analytics to prove the efficacy of targeted research funding, potentially influencing larger philanthropic trends.

Technology and Retention Statistics:
Industry data from the Nonprofit Fundraising Report indicates that organizations using integrated CRM/Fundraising platforms like Bloomerang see an average increase of 15-20% in donor retention compared to those using disconnected third-party crowdfunding sites. For a research-heavy organization like METAvivor, retaining a donor over five years can mean the difference between funding one pilot study and funding a multi-year clinical trial.


IV. Official Responses and Strategic Vision

In communications addressed to the METAvivor community, the organization expressed a mix of gratitude and forward-looking ambition. The shift is framed not merely as a technical update, but as a commitment to the "Metavivor family."

"We are incredibly grateful for the continued support of our community," the organization stated in its official transition brief. "The move to Bloomerang Fundraising allows us to provide a more seamless experience for our fundraisers, who are the lifeblood of our research funding. This platform offers better tools for our supporters to share their stories and for us to ensure that every dollar raised is tracked with the highest level of integrity."

The organization also addressed the potential hurdles of such a move. "We recognize that change can be challenging, particularly for our long-term supporters who have become accustomed to the previous interface. Our team is fully committed to providing the one-on-one support necessary to make this transition successful."

Industry analysts suggest that METAvivor’s move is part of a broader trend where non-profits are seeking "all-in-one" solutions to reduce the "tech stack fatigue" that often plagues volunteer-led organizations. By centralizing operations in Bloomerang, METAvivor reduces administrative overhead, ensuring that more funds remain available for the competitive grant process.


V. Implications for the Philanthropic Sector and MBC Advocacy

The migration from GoFundMe Pro to Bloomerang carries several long-term implications for the non-profit sector and the specific fight against metastatic breast cancer.

1. Data-Driven Advocacy
With Bloomerang’s advanced reporting tools, METAvivor will be able to identify geographic and demographic trends in giving more accurately. This data is vital for "Metavivor’s Stage IV Stampede," an annual advocacy event where patients meet with lawmakers. Having precise data on where their funding comes from allows advocates to present a stronger case for federal research funding (such as through the Department of Defense’s Breast Cancer Research Program).

2. Security and Transparency
In an era of increasing cybersecurity threats, moving to a platform with specialized non-profit security protocols is a defensive necessity. Bloomerang’s focus on the non-profit sector means its compliance measures are tailored to the specific needs of charitable giving, providing donors with peace of mind that their financial data is handled according to the highest industry standards.

3. The Evolution of P2P Giving
The transition highlights the evolution of peer-to-peer giving from "viral moments" to "sustained relationships." While platforms like GoFundMe are excellent for one-time emergency needs, research-based non-profits require sustained, multi-year engagement. Bloomerang’s interface encourages "recurring giving" and "milestone fundraising," which aligns better with the long-term nature of medical research.

4. Addressing the "Fall Transition" Challenge
By completing the migration in the fall, METAvivor is positioning itself for the "Giving Tuesday" and end-of-year holiday donation surge. Historically, the last quarter of the year accounts for nearly 30% of all annual giving. Having a stable, high-performance platform in place before this window is critical for hitting the organization’s annual research funding targets.

Conclusion

METAvivor’s transition to Bloomerang is more than a change of website; it is a strategic reinvestment in the infrastructure of hope. For the metastatic breast cancer community, where time is the most precious commodity, the efficiency of a fundraising platform can have real-world consequences on the speed of scientific discovery.

Fundraisers who have not yet accessed their new dashboards are encouraged to search their inboxes for the July 27 notification or contact the METAvivor support team directly. As the old GoFundMe Pro pages go dark, the organization looks forward to a new chapter of growth, driven by a platform that matches the sophistication and dedication of its supporters.

Through this technological leap, METAvivor reaffirms its core promise: to remain the leading voice for the metastatic community and to ensure that the search for a cure continues unabated, supported by the most efficient tools available in the modern philanthropic landscape.

About the Author

Layla Zulfa

Author

View All Posts

Post navigation

Previous: A New Era in Oncology: Karen and Rob Hale Commit Historic $50 Million to Revolutionize Breast Cancer Research

Related Stories

a-new-era-in-oncology-karen-and-rob-hale-commit-historic-50-million-to-revolutionize-breast-cancer-research
  • Patient Advocacy and Support

A New Era in Oncology: Karen and Rob Hale Commit Historic $50 Million to Revolutionize Breast Cancer Research

Evan Lee Salim November 2, 2026
bridging-the-gap-how-taylarr-lopez-is-redefining-public-health-communication-and-health-equity
  • Patient Advocacy and Support

Bridging the Gap: How Taylarr Lopez is Redefining Public Health Communication and Health Equity

Azzam Bilal Chamdy November 1, 2026
a-survivors-unwavering-spirit-navigating-the-labyrinth-of-breast-cancer-with-hope-and-resilience
  • Patient Advocacy and Support

A Survivor’s Unwavering Spirit: Navigating the Labyrinth of Breast Cancer with Hope and Resilience

Ali Ikhwan November 1, 2026

Recent Posts

  • Headline: METAvivor Announces Strategic Migration to Bloomerang Fundraising Platform to Bolster Peer-to-Peer Research Funding Initiatives
  • A New Era in Oncology: Karen and Rob Hale Commit Historic $50 Million to Revolutionize Breast Cancer Research
  • Strengthening Global Health Architecture: WHO and Switzerland Formalize Strategic Partnership for 2024–2028
  • Bridging the Evidence Gap: How Boston Scientific is Reshaping Atrial Fibrillation and Stroke Management
  • Beyond the Genome: Why Genetic Counsellors Are the Bedrock of Modern Precision Medicine

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

headline-metavivor-announces-strategic-migration-to-bloomerang-fundraising-platform-to-bolster-peer-to-peer-research-funding-initiatives
  • Patient Advocacy and Support

Headline: METAvivor Announces Strategic Migration to Bloomerang Fundraising Platform to Bolster Peer-to-Peer Research Funding Initiatives

Layla Zulfa November 2, 2026
a-new-era-in-oncology-karen-and-rob-hale-commit-historic-50-million-to-revolutionize-breast-cancer-research
  • Patient Advocacy and Support

A New Era in Oncology: Karen and Rob Hale Commit Historic $50 Million to Revolutionize Breast Cancer Research

Evan Lee Salim November 2, 2026
strengthening-global-health-architecture-who-and-switzerland-formalize-strategic-partnership-for-2024-2028
  • Breast Cancer Prevention and Lifestyle

Strengthening Global Health Architecture: WHO and Switzerland Formalize Strategic Partnership for 2024–2028

Reynand Wu November 2, 2026
bridging-the-evidence-gap-how-boston-scientific-is-reshaping-atrial-fibrillation-and-stroke-management
  • Treatment Innovations

Bridging the Evidence Gap: How Boston Scientific is Reshaping Atrial Fibrillation and Stroke Management

Muslim November 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.